SCHEMBL7195064

SCHEMBL7195064

CCc1ccc(OC)c(CCC(=O)c2cc(OC)ccc2OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TSHR P16473 3/20 0.52
ALDH1A1 P00352 2/20 0.52
GLA P06280 1/20 0.52
NPC1 O15118 1/20 0.50
PKM P14618 1/20 0.50
RAB9A P51151 1/20 0.50
MAPT P10636 2/20 0.48
KDM4E B2RXH2 2/20 0.48
HTT P42858 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD11B1 P28845 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 2/20 0.47
TP53 P04637 1/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196334 0.89 HSD17B10 (0.58) MEN1KMT2ATSHRALDH1A1NPC1
SCHEMBL7193844 0.87 NPC1 (0.51) MEN1KMT2AALDH1A1NPC1PKM
SCHEMBL7190512 0.86 NPC1 (0.44) MEN1KMT2ATSHRALDH1A1GLA
SCHEMBL7198516 0.83 POLB (0.46) MEN1KMT2ATSHRNPC1HTT
SCHEMBL7195034 0.82 ALDH1A1 (0.52) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL7192815 0.82 SLC5A1 (0.44) ALDH1A1NPC1KDM4EHTTMTNR1A
SCHEMBL7193474 0.81 ALDH1A1 (0.45) MEN1KMT2AALDH1A1NPC1PKM
SCHEMBL13227299 0.81 HTT (0.62) MEN1KMT2ATSHRALDH1A1GLA
SCHEMBL7193633 0.80 SLC5A1 (0.46) LMNAMTNR1AMTNR1B
SCHEMBL7193466 0.80 PPARG (0.45) MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 MEN1 3878/4885KMT2A 4485/4885TSHR 1982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.